Compare PRPO & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | SACH |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 38.4M |
| IPO Year | 2000 | 2016 |
| Metric | PRPO | SACH |
|---|---|---|
| Price | $26.25 | $0.95 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 139.2K | ★ 187.0K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 19.23% |
| EPS Growth | 92.15 | ★ 104.30 |
| EPS | N/A | ★ N/A |
| Revenue | $24,049,000.00 | ★ $57,500,000.00 |
| Revenue This Year | N/A | $145.00 |
| Revenue Next Year | N/A | $6.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $16.14 | $0.76 |
| 52 Week High | $33.63 | $1.45 |
| Indicator | PRPO | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 61.43 |
| Support Level | $25.46 | $0.91 |
| Resistance Level | $27.59 | $0.98 |
| Average True Range (ATR) | 1.66 | 0.03 |
| MACD | -0.30 | 0.01 |
| Stochastic Oscillator | 35.39 | 63.08 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.